{"id":"NCT01126437","sponsor":"Boehringer Ingelheim","briefTitle":"Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease","officialTitle":"A Randomized, Active-controlled, Double-blind, Double-dummy, Parallel Group Design, Multi-center Trial to Compare the Efficacy and Safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution Delivered by the Respimat Inhaler With Tiotropium Inhalation Capsules 18 µg Delivered by the HandiHaler (TIOSPIR)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05","primaryCompletion":"2013-05","completion":"2013-05","firstPosted":"2010-05-19","resultsPosted":"2014-06-20","lastUpdate":"2014-06-20"},"enrollment":17183,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"tiotropium 18 mcg","otherNames":[]},{"type":"DRUG","name":"tiotropium 1.25 mcg (2 actuations/day)","otherNames":[]},{"type":"DRUG","name":"tiotropium 2.5 mcg (2 actuations/day)","otherNames":[]}],"arms":[{"label":"tiotropium 2.5 mcg and placebo","type":"EXPERIMENTAL"},{"label":"tiotropium 18 mcg and placebo","type":"ACTIVE_COMPARATOR"},{"label":"tiotropium 5 mcg and placebo","type":"EXPERIMENTAL"}],"summary":"Direct comparison studies of the tiotropium HandiHaler® 18 µg and Respimat® 5 µg formulations have been limited to 4-week crossover studies. Therefore, prospective data from a trial of adequate size and duration is required to establish that compared to tiotropium HandiHaler®, tiotropium Respimat® will have (a) similar effects on safety and (b) similar or superior effects on exacerbations.","primaryOutcome":{"measure":"Time to All-Cause Mortality","timeFrame":"Up to 3 years","effectByArm":[{"arm":"Tiotropium 2.5 mcg and Placebo","deltaMin":440,"sd":7.7},{"arm":"Tiotropium 5 mcg and Placebo","deltaMin":423,"sd":7.4},{"arm":"Tiotropium 18 mcg and Placebo","deltaMin":439,"sd":7.7}],"pValues":[{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1191,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","China","Colombia","Croatia","Denmark","Finland","France","Georgia","Germany","Greece","Guatemala","Hungary","India","Ireland","Israel","Italy","Latvia","Lithuania","Malaysia","Mexico","Netherlands","New Zealand","Norway","Panama","Peru","Philippines","Poland","Portugal","Puerto Rico","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Tunisia","Turkey (Türkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["29497289","28957643","26715479","26369563","23992515"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1932,"n":5724},"commonTop":["Chronic obstructive pulmonary disease"]}}